ISRG

Intuitive Surgical, Inc.

Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.

Intuitive Surgical, Inc. (ISRG) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Revisions (C-). The rating has held at C+ for 3 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
C
Factor Score 2.5 / 5.0
Growth
C-
Factor Score 2.1 / 5.0
Profitability
B
Factor Score 3.2 / 5.0
Momentum
B-
Factor Score 3.1 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 53.6
EV / EBITDA N/A
Rev Growth YoY 21.7%
Gross Margin 66.6%
Price Return 3M 13.6%
Price Return 12M -22.5%
Catalyst Signal +0.08
Market Cap $153.8B
TTM Revenue $11.6B
Price / Sales 13.3
ROE 17.9%

Historical Factor Score Progression

Held C+ for 3 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 C (2.5) C- (2.1) B (3.2) B- (3.1) C- (1.9) C+ (2.6)
2026-11-09 C- (2.1) C- (2.1) B (3.2) B- (3.0) B- (3.1) C+ (2.7)
2026-11-02 C (2.2) C- (2.1) B (3.2) C+ (2.8) B- (3.1) C+ (2.7)
2026-10-27 C (2.2) C- (2.1) B (3.2) C+ (2.7) C (2.4) C+ (2.5)
2026-10-26 C (2.2) C- (2.1) B- (3.1) C+ (2.7) C+ (2.5) C+ (2.5)
Page 1 of 10
…